Gomez, Baby Girl .
HRN: 26-58-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/19/2025
02/26/2025
IV
40mg
Q24
Acute Bacterial Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes